Originally published Saturday, March 15, 2008 at 12:00 AM
Heparin probe studies supply chain
The investigation into a blood thinner suspected in 19 U.S. deaths is focusing on the possibility that raw biological ingredients were...
Los Angeles Times
WASHINGTON — The investigation into a blood thinner suspected in 19 U.S. deaths is focusing on the possibility that raw biological ingredients were contaminated even before they reached a factory in China, manufacturer Baxter International said Friday.
That raises the prospect that the problem could have occurred somewhere along a supply chain that includes layers of middlemen and originates in pig farms. The generic medication, heparin, is derived from a substance found in the lining of pig intestines. It is used widely to prevent dangerous blood clots from forming during kidney dialysis and cardiac surgery.
The case has reinforced concerns about quality-control problems with Chinese products. But unlike last year's pet-food recall, it was frail patients who suffered the ill effects of the drug contamination. Some suffered life-threatening allergic reactions.
The Food and Drug Administration (FDA) announced new testing requirements for all imported heparin Friday. Manufacturers who do not agree in advance to sophisticated safety tests will have their shipments held at ports of entry until the government can test them.
FDA officials said they are close to identifying the mysterious look-alike ingredient that contaminated the Baxter heparin and prompted a recall in February. The substance, which acts much like heparin, could not be detected with conventional tests for drug purity and potency.
Once the contaminant is identified, investigators should be able to tell more about whether it was added deliberately or occurred naturally or as a result of a problem with processing, FDA Deputy Commissioner Janet Woodcock said.
"We are very close," she said. "When we complete that, [it] will help our understanding of how it got in."
The source of the contamination might remain murky, however, if it occurred along the chain of farmers and middlemen who handle the material in China, where the FDA's regulatory reach does not currently extend and where local manufacturing standards have been called into question.
The FDA announced Friday that it hopes to place regulators in China, pending approval from the Chinese government.
The State Department approved a plan to establish eight full-time, permanent FDA positions at U.S. diplomatic posts in China. The agency also plans to hire five Chinese employees to work with it at the U.S. Embassy in Beijing and the U.S. consulates in Shanghai and Guangzhou.
"Our efforts to fill permanent FDA positions in China are a significant step toward ensuring access to safe food, drugs and medical devices in the global market," said Murray Lumpkin, the FDA's deputy commissioner for international and special programs.
Copyright © 2008 The Seattle Times Company
UPDATE - 10:01 AM
Rebels tighten hold on Libya oil port
UPDATE - 09:29 AM
Reality leads US to temper its tough talk on Libya
UPDATE - 09:38 AM
2 Ark. injection wells may be closed amid quakes
Armed guards save Dutch couple from Somali pirates
Navy to release lewd video investigation findings

general classifieds
Garage & estate salesFurniture & home furnishings
Electronics
just listed
Nikon D700 (Body Only) - As New Condition!
2001 SeaRay 380DA
AKC Chocolate Labrador Puppies
More listings
POST A FREE LISTING
- Madrona dad killed by a bullet as he drove through Central Area
- Matt Flynn has good day in Seahawks' 3-way QB competition
- Why dealing for Kellen Winslow makes sense for Seahawks | Steve Kelley
- Facebook messages trigger melee at Whitman Middle School
- Komen controversy hurting Race for the Cure
- Ex-boyfriend sought in death of Renton girl, 17
- Driver fatally shot in Central Area
- Brandon League looks out of his own for Mariners
- Opponents of gay-marriage law get unexpected aid: from Muslims
- Juror alternates' actions have court on red alert
- Opponents of gay-marriage law say they have enough signatures
874 - Mariners look to get back on winning track against Angels
475 - Madrona dad killed by stray bullet as he drove through Central Area
340 - Komen controversy hurting Race for the Cure
221 - Typical CEO made $9.6M last year, AP study finds
154 - Fact check: Ad exaggerates Obama's debt
99 - Seattle police twice face hostile crowds at scenes of violence crime
89 - The Seattle area's scandalous lack of adequate transit capacity
69 - May questions, volume seven
51 - Brandon League looks out of his own for Mariners
48
- Madrona dad killed by a bullet as he drove through Central Area
- Driver fatally shot in Central Area
- Facebook messages trigger melee at Whitman Middle School
- Downtown building fetches $55M, thanks to Amazon effect
- Opponents of gay-marriage law get unexpected aid: from Muslims
- Get a sitter — please — for these 10 great date-night restaurants | All You Can Eat
- Komen controversy hurting Race for the Cure
- Rescued teen tells author how story helped him survive
- Sounders FC salaries released for 2012 season | Sounders FC Blog
- 520 bridge builders pledge to look into beer drinking
